Despite the best intentions and brightest innovation, start-ups haven’t been able to tap into the huge potential presented by the vascular closure market. But the opportunity simply is too big for the
The next generation of protection companies knows they need more than just good clinical data to drive adoption. by Stephen Levin Nowhere in medicine have clinicians and product companies more heavily